Project Leader

PD. Dr. Justo Lorenzo Bermejo


Institute of Medical Biometry and Informatics

University of Heidelberg

Im Neuenheimer Feld 305

69120 Heidelberg

Phone: 06221/56 4180

Email: Justo.Lorenzo@imbi.uni-heidelberg.de

Academic Education and scientific Degrees

1998-2002             PhD in Quantitative Genetics, Christian-Albrechts University of Kiel (CAU), Germany

1993-2003             Mathematics, Spanish Open University (UNED)

1990-1997             Engineering, Polytechnic University of Madrid (UPM), Spain

Professional Career

since 2009            Leader of Statistical Genetics Group, Institute of Medical Biometry and Informatics, University of Heidelberg, Germany

since 2003            Scientist, Division of Molecular Genetic Epidemiology, German Cancer Research Center

2002-2003             Statistical Consultant, Information-Works GmbH, Hamburg, Germany


since 2012            Member of the 22nd Annual Conference and the Committee on Ethical, Legal, and Social Issues of the International Genetic Epidemiology Society

since 2011            Deputy representative of the Working Group Genetic Epidemiology, German Epidemiology Society

Awards and Appointments

2006/2010             Grants for advanced courses, Wellcome Trust UK

2004                     Award for outstanding professional achievement, German Cancer Research Center

2003                     Distinction in the course “Advanced methods in applied statistics”, Spanish Open University


Selected Publications

  1. Chaisaingmongkol J, Popanda O, Warta R, Dyckhoff G, Herpel E, Geiselhart L, Claus R, Lasitschka F, Campos B, Oakes CC, Lorenzo Bermejo J, Herold-Mende C, Plass C, Schmezer P (2012) Epigenetic screen of human DNA repair genes identifies aberrant promoter methylation of NEIL1 in head and neck squamous cell carcinoma. Oncogene 31:5108-16.
  2. Faryna M, Konermann C, Aulmann S, Lorenzo Bermejo J, Brugger M, Diederichs S, Rom J, Weichenhan D, Claus R, Rehli M, Schirmacher P, Sinn HP, Plass C, Gerhauser C (2012) Genome-wide methylation screen in low-grade breast cancer to identify novel diagnostic and prognostic markers FASEB 26:4937-50.
  3. Neumann O, Kesselmeier M, Geffers R, Pellegrino R, Radlwimmer B, Hoffmann K, Ehemann V, Schemmer P, Schirmacher P, Lorenzo Bermejo J, Longerich T (2012) Methylome analysis and integrative profiling of human HCCs identify novel protumorigenic factors Hepatology 56:1817-27.
  4. Lorenzo Bermejo J, Garcia Perez A, Brant A, Hemminki K, Matthews AG (2011) Comparison of six statistics of genetic association regarding their ability to discriminate between causal variants and genetically linked markers. Hum Hered 72:142-152.
  5. Campos B, Centner FS, Lorenzo Bermejo J, Dorsch K, Felsberg J, Ahmadi R, Grabe N, Lichter P, Reifenberger G, Unterberg A, Herold-Mende C (2011) Aberrant expression of retinoic acid signalling molecules influences patient survival in astrocytic gliomas Am J Pathol 178:1953-64.
Impressum          © SFB/TRR77 Livercancer        Webdesign: ki-werkstatt, Karlsruhe.